000963:SHE
Huadong Medicine Co., Ltd.
CNÂ¥27.60
arrow_upward
+1.51%(+0.41) 1D
Nov 4, 3:04:24 PM GMT+8 · CNY
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 000963...
Open
CNÂ¥27.20
High
CNÂ¥27.80
Low
CNÂ¥27.19
Mkt. cap
47.68B
Avg. vol.
14.64M
Volume
25.40M
Dividend
3.37%
Quarterly dividend
CNÂ¥0.23
Ex-dividend date
Sep 18, 2026
P/E ratio
14.08
52-wk high
CNÂ¥43.78
52-wk low
CNÂ¥25.63
EPS
CNÂ¥1.96
Shares outstanding
1.75B
No. of employees
19K
Open
CNÂ¥27.20
High
CNÂ¥27.80
Low
CNÂ¥27.19
Mkt. cap
47.68B
Avg. vol.
14.64M
Volume
25.40M
Dividend
3.37%
Quarterly dividend
CNÂ¥0.23
Ex-dividend date
Sep 18, 2026
P/E ratio
14.08
52-wk high
CNÂ¥43.78
52-wk low
CNÂ¥25.63
EPS
CNÂ¥1.96
Shares outstanding
1.75B
No. of employees
19K
Related stocks
News stories
From web sources and news partners
Virginia Business
·
46 minutes ago
Accendra Health could be delisted by NYSE
RealMoney Pro
·
8 minutes ago
First Day of Trading After Midterms Proves a Challenge
Yahoo Finance
·
29 minutes ago
The Nasdaq-100 Is Outperforming Nvidia, Microsoft, Amazon, Meta Platforms, Alphabet, and Tesla This Year. Here's My Favorite Low-Cost ETF to Buy the Dip.
The Washington Post
·
2 hours ago
The S&P 500 climbs after Democrats sweep the midterms
Profile
HD Medicine, or Huadong Medicine Co., Ltd., is a Hangzhou-based pharmaceutical company registered on the Shenzhen Stock Exchange since December 1999. It has a listed share capital of 380,000,000 RMB and a market capitalization of 5.1981 billion RMB as of June 2026. It is the largest pharmaceutical company in Zhejiang and the leading immunosuppressant manufacturer in China.
In June 2025, the company received approval to commence clinical trials for Roflumilast Foam, targeting dermatological conditions. Wikipedia
About Huadong Medicine Co., Ltd.
CEO-
Employees19.1K
FoundedMar 31, 1993
Headquarters-
SectorHealth care provider
Industry-
Websiteeastchinapharm.com